• Daily study support for in vivo pharmacology studies (efficacy, PK/PD) including dosing, measuring tumors, collecting tissues
• Pre-clinical model development and characterization
• Accurate/timely record keeping and data analysis of in vivo data
• Work closely with project teams to design in vivo studies
• Cell culture
• Operation and maintenance of laboratory equipment

• BS with 0-2 years of hands on experience or demonstrate equivalent work experience with murine models of cancer, inflammation and/or immunology
• Experience with various mouse handling techniques including dosing (IV, PO, subcutaneous, IP), tumor inoculation/measurements, in life and terminal blood collection, collection and handling of tissues during necropsy and processing for ex vivo analysis
• Working knowledge of laboratory animal equipment and supplies, for a variety of common laboratory animals and personal protective equipment requirements for various bio-safety levels.
• Demonstrated ability to organize and plan studies and execute day-to-day responsibilities with minimum supervision
• Experience with in vivo imaging is desired
• Experience with cell culture is desired
• Computer literacy, especially proficiency with Graph Pad Prism, Excel, Power Point and Word
• Excellent organizational and communication skills, along with the ability to work effectively in a multidisciplinary team environment

The salary range for this position is: $80,325.00 - $103,950.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*.

• Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.